Display options
Cite
Goldstein DA, Clark J, Tu Y, et al. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth. Oncotarget. 2017;8(42):71548-71555doi: 10.18632/oncotarget.17742.
Goldstein, D. A., Clark, J., Tu, Y., Zhang, J., Fang, F., Goldstein, R., Stemmer, S. M., & Rosenbaum, E. (2017). A global comparison of the cost of patented cancer drugs in relation to global differences in wealth. Oncotarget, 8(42), 71548-71555. https://doi.org/10.18632/oncotarget.17742
Goldstein, Daniel A, et al. "A global comparison of the cost of patented cancer drugs in relation to global differences in wealth." Oncotarget vol. 8,42 (2017): 71548-71555. doi: https://doi.org/10.18632/oncotarget.17742
Goldstein DA, Clark J, Tu Y, Zhang J, Fang F, Goldstein R, Stemmer SM, Rosenbaum E. A global comparison of the cost of patented cancer drugs in relation to global differences in wealth. Oncotarget. 2017 May 09;8(42):71548-71555. doi: 10.18632/oncotarget.17742. eCollection 2017 Sep 22. PMID: 29069727; PMCID: PMC5641070.
Copy Download .nbib Format: NLM
Share it on

Oncotarget. 2017 May 09;8(42):71548-71555. doi: 10.18632/oncotarget.17742. eCollection 2017 Sep 22.

A global comparison of the cost of patented cancer drugs in relation to global differences in wealth.

Oncotarget

Daniel A Goldstein, Jonathon Clark, Yifan Tu, Jie Zhang, Fenqi Fang, Robert Goldstein, Salomon M Stemmer, Eli Rosenbaum

Affiliations

  1. Davidoff Cancer Center, Rabin Medical Center, Petach Tikvah, Israel.
  2. Winship Cancer Institute, Emory University, Atlanta, GA, USA.
  3. Saint Louis University Hospital, St. Louis, MO, USA.
  4. First Affiliated Hospital of Dalian Medical University, Dalian, China.
  5. University College London, London, UK.
  6. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

PMID: 29069727 PMCID: PMC5641070 DOI: 10.18632/oncotarget.17742

Abstract

INTRODUCTION: There are major differences in cancer drug prices around the world. However, the patterns of affordability of these drugs are poorly understood. The objective of this study was to compare patterns of affordability of cancer drugs in Australia, China, India, Israel, South Africa, the United Kingdom, and the United States.

RESULTS: Cancer drug prices are highest in the United States. Cancer drugs are the least affordable in India by a large margin. Despite lower prices than in the USA, cancer drugs are less affordable in middle-income countries than in high-income countries.

MATERIALS AND METHODS: We obtained the prices of a basket of cancer drugs in all 7 countries, and converted the prices to US$ using both foreign exchange rates and purchasing power parity. We assessed international differences in wealth by collecting values for gross domestic product (GDP) per capita in addition to average salaries. We compared patterns of affordability of cancer drugs by dividing the drug prices by the markers of wealth.

CONCLUSIONS: Cancer drugs are less affordable in middle-income countries than in high-income countries. Differential pricing may be an acceptable policy to ensure global affordability and access to highly active anti-cancer therapies.

Keywords: affordability; cost

Conflict of interest statement

CONFLICTS OF INTEREST All authors have no conflicts of interest to declare.

References

  1. BMJ. 2002 Jan 26;324(7331):214-6 - PubMed
  2. N Engl J Med. 2005 Oct 20;353(16):1659-72 - PubMed
  3. J Clin Oncol. 2015 Apr 1;33(10):1112-8 - PubMed
  4. J Clin Oncol. 2008 Apr 20;26(12):2013-9 - PubMed
  5. PLoS Med. 2016 May 31;13(5):e1002032 - PubMed
  6. Ann Oncol. 2015 Aug;26(8):1547-73 - PubMed
  7. J Clin Oncol. 2016 Mar 20;34(9):902-9 - PubMed
  8. Lancet Oncol. 2016 Jan;17(1):39-47 - PubMed
  9. J Clin Oncol. 2014 Apr 20;32(12):1277-80 - PubMed
  10. N Engl J Med. 2001 Apr 5;344(14):1031-7 - PubMed
  11. J Econ Perspect. ;29(1):139-62 - PubMed
  12. Value Health. 2010 Jan-Feb;13(1):28-33 - PubMed
  13. Health Aff (Millwood). 2013 Jun;32(6):1143-52 - PubMed
  14. JAMA Intern Med. 2016 Jan;176(1):65-73 - PubMed
  15. JAMA Oncol. 2015 Sep;1(6):729-30 - PubMed
  16. J Clin Oncol. 2015 Aug 10;33(23):2563-77 - PubMed

Publication Types